In vitro antifungal activity of naphthoquinone derivatives

Biological and Pharmaceutical Bulletin

Volumn 25, Issue 5, 2002, Pages 669-670

  Sasaki, Kenroh ^a   Abe, Hidetomo ^b,c   Yoshizaki, Fumihiko ^a  

^a TOHOKU PHARMACEUTICAL UNIVERSITY   (Japan)

^b Senseki Hospital   (Japan)

^c Do Planning Ltd   (Japan)

Author keywords

hydroxyisovaleryl shikonin; Acetylshikonin; Antifungal activity; Deoxyshikonin; Shikonin

Indexed keywords

(3 HYDROXYISOVALERYL)SHIKONIN; 1,4 NAPHTHOQUINONE DERIVATIVE; ACETYLSHIKONIN; DEOXYSHIKONIN; FLUCONAZOLE; SHIKONIN DERIVATIVE; UNCLASSIFIED DRUG; ANTIFUNGAL AGENT; NAPHTHOQUINONE; PLANT EXTRACT;

ANTIFUNGAL ACTIVITY; ARTICLE; CANDIDA GLABRATA; CANDIDA KRUSEI; CONTROLLED STUDY; DRUG ACTIVITY; DRUG POTENCY; DRUG SCREENING; DRUG SENSITIVITY; FUNGUS; IN VITRO STUDY; LITHOSPERMUM ERYTHRORHIZON; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PATHOGENESIS; PLANT; PLANT ROOT; RECORDING; SACCHAROMYCES CEREVISIAE; STANDARD; TRICHOSPORON CUTANEUM; YEAST; CHEMISTRY; DRUG EFFECT; ISOLATION AND PURIFICATION; LITHOSPERMUM; MICROBIOLOGICAL EXAMINATION;

ANTIFUNGAL AGENTS; FUNGI; LITHOSPERMUM; MICROBIAL SENSITIVITY TESTS; NAPHTHOQUINONES; PLANT EXTRACTS;

EID: 0036581930     PISSN: 09186158     EISSN: None     Source Type: Journal    
DOI: 10.1248/bpb.25.669     Document Type: Article

References (20)

1. Lee S. H., Lee J. R., Lunde C. S., Kubo I., Planta Medica, 65, 204-208 (1999).
2. Dixon D. M., McNeil M. M., Cohen M. L., Gellin B. G., LaMontagne J. R., Public Health Rep., 111, 226-235 (1996).
3. Georgopapadakou N. H., Walsh T. J., Science, 264, 371-373 (1994).
4. Rex J. H., Rinaldi M. G., Pfaller M. A., Antimicrob. Agents Chemother., 39, 1-8 (1995).
5. Sternberg S., Science, 266, 1632-1634 (1994).
6. Patton L. L., Bonito A. J., Shugars D. A., Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod., 92, 170-179 (2001).
7. Wilson M. J., Williams D. W., Forbes M. D., Finlay I. G., Lewis M. A., J. Oral Pathol. Med., 30, 206-212 (2001).
8. Sasaki K., Yoshizaki F., Abe H., Yakugaku Zasshi, 120, 587-589 (2000).
9. Hisamichi S., Yoshizaki F., Shoyakugaku Zasshi, 36, 154-159 (1982).
10. National Committee for Clinical Laboratory Standards M27-A, Wayne, Pa., 1997.
11. National Committee for Clinical Laboratory Standards M38-P, Wayne, Pa., 1998.
12. Tanaka S., Tajima M., Tsukada M., Tabata M., J. Nat. Prod., 49, 466-469 (1986).
13. Chang Y.S., Kuo S. C., Weng S. H., Jan S. C., Ko F. N., Teng C. M., Planta Medica., 59, 401-104 (1993).
14. Hayashi M., Folia Pharmacol. Japon., 73, 193-203 (1977).
15. Sekine T., Kojima K., Matsumoto T., Yamamoto T., Maitani Y., Nagai T., Biol. Pharm. Bull., 21, 950-952 (1998).
16. Konoshima T., Kozuka M., Koyama J., Okatani T., Tagahara K., Tokuda H., J. Nat. Prod., 52, 987-998 (1989).
17. Tanaka Y., Odani T., Yakugaku Zasshi, 92, 525-530 (1972).
18. Sekine T., Kojima K., Ota S., Matsumoto T., Yamamoto T., Maitani Y., Nagai T., Pharm. Sci., 8, 249-253 (1998).
19. Lindy A. B., Paula J. M., Hector E. F., Plant. Physiology. 119, 417-428 (1999).
20. Watimo T. M., Orstavik D., Meurman J. H., Samaranayake L. P., Haapasalo M. P., Oral. Microbiol. Immunol., 15, 245-248 (2000).